Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Severe staphylococcal or other Gram-positive infections, Endocarditis Age: Adult |
Dose: Intravenous – 500 mg Frequency: every 6 hours Note: Infused over at least 60 minutes. |
|
Indication: Severe staphylococcal or other Gram-positive infections, Endocarditis Age: Adult |
Dose: Intravenous – 1 g Frequency: every 12 hours Note: Infused over at least 100 minutes. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Severe staphylococcal or other Gram-positive infections, Endocarditis Age: less than 1 month Condition: Neonates in first week of life |
Dose: Intravenous – 15 mg/kg followed by 10 mg/kg Frequency: every 12 hours Note: Longer dosing intervals recommended in premature infants |
|
Indication: Severe staphylococcal or other Gram-positive infections, Endocarditis Age: less than 1 month Condition: Neonates after first week of life up to 1 month of age |
Dose: Intravenous – 15 mg/kg followed by 10 mg/kg Frequency: every 8 hours Note: Longer dosing intervals recommended in premature infants |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment: Patient on intermittent haemodialysis (Loading dose) |
Dose: Not mentioned – 15-25 mg/kg Frequency: Day 1 Note: Followed by 5-10 mg/kg maintenance dose after each dialysis run |
|
Condition: Renal impairment: Patient on intermittent haemodialysis (Maintenance dose) |
Dose: Not mentioned – 5-10 mg/kg Frequency: After each dialysis run |
Administration
- For IV use only
- Must be administered slowly over 60 minutes
Side Effect
- Erythematous rash on face and upper body (red neck or red man syndrome
- related to infusion rate)
- Hypotension accompanied by flushing
- Chills
- Drug fever
- Eosinophilia
- Rash
- Reversible neutropenia
- Phlebitis
- Nephrotoxicity
- Ototoxicity (especially with large doses)
- Stevens-Johnson syndrome
- Thrombocytopenia
- Vasculitis
- Stevens-Johnson syndrome
- toxic epidermal necrolysis
- blood dyscrasias such as neutropenia or thrombocytopenia
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
General anaesthetics
|
May enhance the adverse effects of vancomycin
|
|
Aminoglycosides, polymyxins, ciclosporin, cisplatin, loop diuretics (Furosemide, Bumetanide, Ethacrynic acid, Torsemide)
|
Increased risk of ototoxicity and nephrotoxicity
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Hypersensitivity to Drug
|
Risk of severe allergic reaction
|
|
History of Impaired Hearing
|
Risk of worsening hearing loss
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool and dry place, protected from light. Keep out of reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.